Abstract 5587: Regulator of chromosome condensation 1 (RCC1) as a novel therapeutic target in pancreatic ductal adenocarcinoma

作者
Sahar F. Bannoura,Husain Yar Khan,Amro Aboukameel,Md. Hafiz Uddin,Rund Nimri,Eliza Wright Beal,Seongho Kim,Mohammed Najeeb Al Hallak,Bassel F. El‐Rayes,Philip A. Philip,Boris Pasche,Ramzi M. Mohammad,Asfar Sohail Azmi
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 5587-5587
标识
DOI:10.1158/1538-7445.am2024-5587
摘要

Abstract Background and Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with limited treatment options. There is an urgent need for the identification of novel therapeutic targets for PDAC. The transport of molecular cargo between the nucleus and cytoplasm, facilitated by Ran-GTPase, is a critical process that dividing cells rely on to maintain their growth. Elevated nuclear Ran-GTP levels are produced by the activity of the Ran guanine nucleotide exchange factor (GEF) known as Regulator of Chromosome Condensation 1 (RCC1), which is found in the nucleus bound to chromatin. This creates a Ran-GTP gradient across the nuclear membrane, which maintains proper directional transport of proteins and RNA. To sustain proliferative signaling, cancer cells become reliant on high rates of nucleocytoplasmic transport through dysregulation of transport machinery. Methods: We examined the role of RCC1 in the biology of PDAC. The impact of RCC1 modulation on PDAC growth was evaluated using RNA interference and CRISPR-Cas9 in vitro and in vivo using PDAC cell lines and LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx1-Cre (KPC) tumor-derived cells. The broader impact of RCC1 silencing on PDAC-sustaining signaling was evaluated through RNA-sequencing and proteomics. Results: Transcriptomic sequencing of PDAC tissue (n=5,071) as well as analysis of publicly available data from the TCGA, CPTAC and GTEx revealed that RCC1 expression is higher in PDAC tissues compared to normal pancreas. Moreover, PDAC patients with higher RCC1 expression were more likely to have poorer outcomes. RCC1 silencing by RNAi and CRISPR-Cas9 resulted in reduced proliferation in 2D and 3D cultures and attenuated tumor growth in vivo. RCC1 KD decreased migration and colony formation, enhanced apoptosis, and altered the cell cycle in human and KPC mouse PDAC cells. Subcutaneous RCC1 KO cell line-derived xenografts show arrested growth. Subcellular Ran distribution was disrupted upon RCC1 KO, suggesting that nuclear Ran concentration is important for PDAC proliferation. Nuclear and cytosolic proteomic analysis revealed altered subcellular proteome in RCC1 KD KPC tumor-derived cells. Altered cytoplasmic protein pathways include several metabolic pathways, PI3K-AKT, and Hedgehog signaling. Nuclear enriched pathways include cell cycle, mitosis, metabolic processes, and RNA processing. RNA-seq of RCC1 KO cells showed widespread transcriptional alterations. Upstream of RCC1, c-MYC activates the RCC1-RAN axis, and RCC1 KO cells show differential sensitivity to c-MYC inhibitors. Finally, RCC1 KD resulted in the sensitization of PDAC cells to Gemcitabine. Molecular characterization of conditional Rcc1fl/fl KO transgenic model to study the role of RCC1 in PDAC in vivo is ongoing. Conclusions: Overall, our results show that RCC1 is involved in the regulation of PDAC growth and is a potential target for therapy. Citation Format: Sahar F. Bannoura, Husain Y. Khan, Amro Aboukameel, Md Hafiz Uddin, Rund Nimri, Eliza Beal, Seongho Kim, Mohammed Najeeb Al Hallak, Bassel El-Rayes, Philip A. Philip, Boris Pasche, Ramzi Mohammad, Asfar S. Azmi. Regulator of chromosome condensation 1 (RCC1) as a novel therapeutic target in pancreatic ductal adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 5587.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿的应助被顺利毕业采纳,获得10
刚刚
乐乐的应助被香辣土豆丝采纳,获得10
刚刚
深情安青的应助被zhl采纳,获得10
刚刚
blue发布了新的文献求助10
1秒前
11完成签到,获得积分10
1秒前
榛子田发布了新的文献求助10
2秒前
希望天下0贩的0的应助被H11103y采纳,获得10
2秒前
renpp822发布了新的文献求助10
2秒前
仁爱的怜南完成签到,获得积分10
3秒前
不知道名字可以起多长完成签到,获得积分10
3秒前
科目三的应助被毛旭文采纳,获得30
3秒前
3秒前
科研通AI6.3的应助被求学采纳,获得10
5秒前
IY发布了新的文献求助10
5秒前
xing_xing的应助被Mine采纳,获得20
5秒前
sunshiny完成签到,获得积分10
6秒前
王白石发布了新的文献求助10
6秒前
李晨语完成签到,获得积分10
6秒前
酱啊油完成签到,获得积分10
6秒前
风吹麦浪的应助被1234567采纳,获得10
7秒前
xiaoxiaoshu完成签到,获得积分10
7秒前
7秒前
领导范儿的应助被1234567采纳,获得10
7秒前
Ava的应助被111采纳,获得10
7秒前
糖淘淘完成签到,获得积分10
7秒前
8秒前
yuliuism发布了新的文献求助10
8秒前
9秒前
11秒前
xiaocao发布了新的文献求助10
11秒前
闪闪凝梦发布了新的文献求助20
11秒前
JamesPei的应助被zhikaiyici采纳,获得30
11秒前
12秒前
钟梓袄发布了新的文献求助10
12秒前
12秒前
现实的无心完成签到 ,获得积分10
13秒前
nissy完成签到,获得积分10
14秒前
15秒前
草莓软糖发布了新的文献求助10
15秒前
zhl发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148